Simplified Rapid Hydration in Preventing CA-AKI Among Patients With Chronic Kidney Disease

NCT02232997 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1002

Last updated 2022-10-03

No results posted yet for this study

Summary

No well-defined protocols exist to guide fluid administration for prevention of contrast-associated acute kidney injury in high risk patients. The investigators will compare long term hydration at routine speed(12h before and after procedure at 1ml/kg/h) with short term hydration at high speed(1h before and 4h after procedure at 3ml/kg/h) to verify our hypothesis that the short term hydration may not be inferior to the long one.

Conditions

Interventions

OTHER

Standard Hydration

Sodium chloride hydration was set between 12 hours before coronary intervention (before contrast exposure during coronary angiography), continued during procedure, and 12 hours after procedure at 1 ml/kg/h (0.5 ml/kg/h For patients with congestive heart failure, New York Heart Association class\>II, or LVEF \< 35%). For patients weighing more than 80 kg, bolus and infusion rates are limited to calculated values for patients weighing 80 kg

OTHER

Simplified Hydration

Hydration with sodium chloride was set 1 hour before procedure (before contrast exposure during coronary angiography), continued during procedure, and 4 hours after procedure at 3ml/kg/h (1.5ml/kg/h For patients with congestive heart failure, New York Heart Association class\>II, or LVEF \<35%). For patients weighing more than 80 kg, bolus and infusion rates are limited to those calculated for patients weighing 80 kg.

Sponsors & Collaborators

  • Peking University First Hospital

    collaborator OTHER
  • Fudan University

    collaborator OTHER
  • The General Hospital of Northern Theater Command

    collaborator OTHER
  • Xiamen Cardiovascular Hospital, Xiamen University

    collaborator OTHER
  • First Affiliated Hospital of Guangxi Medical University

    collaborator OTHER
  • Sichuan Provincial People's Hospital

    collaborator OTHER
  • Wuhan Asia Heart Hospital

    collaborator OTHER
  • West China Hospital

    collaborator OTHER
  • Jining Medical University

    collaborator OTHER
  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER
  • Fujian Provincial Hospital

    collaborator OTHER
  • First Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER
  • Fuling Central Hospital of Chongqing City

    collaborator OTHER
  • Second Xiangya Hospital of Central South University

    collaborator OTHER
  • People's Hospital of Guangxi Zhuang Autonomous Region

    collaborator OTHER
  • Maoming People's Hospital

    collaborator OTHER
  • Xijing Hospital

    collaborator OTHER
  • Beijing Friendship Hospital

    collaborator OTHER
  • Tangshan Gongren Hospital

    collaborator OTHER
  • Xuzhou Central Hospital

    collaborator OTHER
  • Southern Medical University, China

    collaborator OTHER
  • Guangdong Provincial People's Hospital

    lead OTHER

Principal Investigators

  • Jiyan Chen, MD · Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital

  • Yong Liu, MD · Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital

  • Yong Huo, MD · Peking University First Hospital

  • Junbo Ge, MD · Fudan University

  • Pingyan Chen, MS · Southern Medical University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02232997 on ClinicalTrials.gov